In a recent study, researchers investigated the mechanisms the bacteria Pseudomonas aeruginosa uses to adapt specifically to patients with bronchiectasis. The study was recently published in the journal BMC Genomics.

The findings suggest that although the Pseudomonas aeruginosa PAHM4 strain shares common phenotypes of pathogenesis between different infection environments, this strain also has genetic and phenotypic traits that are niche-specific, being activated only in bronchiectasis conditions.